| Patents for A61P 1 - Drugs for disorders of the alimentary tract or the digestive system (125,798) |
|---|
| 06/10/2004 | WO2003084943A9 Terphenyl derivatives, preparation thereof, compositions containing same |
| 06/10/2004 | WO2003083039A8 Therapeutic polypeptides, nucleic acids encoding same, and methods of use |
| 06/10/2004 | WO2003072027A3 Compositions and formulations of 9- nitrocamptothecin polymorphs and methods of use thereof |
| 06/10/2004 | WO2003070970A3 RNA INTERFERENCE MEDIATED INHIBITION OF NF-KAPPA B/REL-A GENE EXPRESSION USING SHORT INTERFEREING NUCLEIC ACID (siNA) |
| 06/10/2004 | WO2003064626A3 Double-stranded oligonucleotides |
| 06/10/2004 | WO2003048116A3 Esters and amides as ppar-alpha agonists ____________ |
| 06/10/2004 | WO2003007800A9 Methods for diagnosing and treating diseases and conditions of the digestive system and cancer |
| 06/10/2004 | WO2002090600A3 A method for regulating immune function in primates using the foxp3 protein |
| 06/10/2004 | US20040110952 e.g., N-[1-(3-phenyl-3-[cyclopenytlacetylamino]propyl)-4-piperidinyl]-N-ethyl-4-methanesulfonylphenylacetamide |
| 06/10/2004 | US20040110945 Very Late Antigen (Vla-4); such as 4-((4S)-fluoro-1-(2-phenylamino-6-benzoxazolylacetyl)-(2S)-pyrrolidinylmethoxy)benzoic acid; for treatment of inflammatory diseases, autoimmune diseases, metastasis, bronchial asthma, rhinostenosis, and diabetes |
| 06/10/2004 | US20040110840 Novel derivatives of dicarboxylic acid having pharmaceutical properties |
| 06/10/2004 | US20040110834 can be used as a medicament, food for special healty uses and a health food that are effective for protection against infection of microorganisms such as pathogenic Escherichia coli such as E. coli or Helicobacter pylori. |
| 06/10/2004 | US20040110833 administering a patient an ester of an alpha-ketoalkanoic acid selected from alpha-ketopropionic acid (pyruvate), alpha-keto-butyrate, alpha-ketopentanoate, alpha-keto-3-methyl-pentanoate etc. to treat cytokine mediated inflammatory conditions |
| 06/10/2004 | US20040110810 e.g., 2-(2-methyl-5-amino)phenyl-4-(3-pyridyl)-thiazole; c-kit inhibitors; treating cell proliferative, metabolic, allergic, and degenerative disorders. |
| 06/10/2004 | US20040110809 di- and tricycle-substituted imidazolidine-, oxazolidine- and thiazolidine diones and thiones, e.g., 5-[p-(quinolin-3-yl)-alpha-hydroxybenzyl]-5-methylimidazolidinedione |
| 06/10/2004 | US20040110805 Sulfur compounds such as 4-[(4-{3-[(2-adamantylamino)sulfonyl]propoxy}phenyl)sulfonyl]- N-hydroxytetrahydro-2H-pyran-4-carboximide, used as antagonists for metalloenzyme and/or aggrecanase activity; tissue repair |
| 06/10/2004 | US20040110801 Prevention of degenerative joint diseases, rheumatoid arthritis, osteoarthritis, ulcerative colitis, irritable colon and Crohn's diseas, antitumor agents; drug mixture for transdermal drug delivery, sustained release; chemical synthesis |
| 06/10/2004 | US20040110794 Novel piperidine derivatives as modulators of chemokine receptors |
| 06/10/2004 | US20040110793 Heterocyclo inhibitors of potassium channel function |
| 06/10/2004 | US20040110779 Hydantoin derivsatives with affinity for somatostatin receptors |
| 06/10/2004 | US20040110768 (S)-3-(1H-indol-3-yl)-N-(1-methoxymethyl-cyclohexylmethyl)-2-methyl-2-[4-(4-nitro-phenyl)-oxazol-2-ylamino]-propionamide for example; cancer, psychological disorders, sexual disorders, eating disorders, inflammatory bowel disease, sleep disorders |
| 06/10/2004 | US20040110763 Pyrazolopyridine compound and pharmaceutical use thereof |
| 06/10/2004 | US20040110759 Inhibitors of IkB kinase (I Kappa B Kinase); treating various diseases including asthma, osteoarthritis, rheumatoid arthritis, Alzheimer's disease, cancer, infections, and cardiac infarct |
| 06/10/2004 | US20040110755 for cytokine-mediated diseases such as Crohn's disease; mixture of an immunosuppressant, NSAIDs, angiogenesis inhibitors, steroids, retinoids, or cellular adhesion molecule inhibitor and specific urea- and morpholine-containing compounds |
| 06/10/2004 | US20040110753 Tyrosine derivatives |
| 06/10/2004 | US20040110752 2-amino-5-((hetero)aryl)-thiazole derivatives; treatment of disorders such as cancer, immunologic disorders and allergic disorders, optionally in combination with other drugs such as immunosuppressants |
| 06/10/2004 | US20040110742 Dihydrodiaryloxazepine derivative and pharmaceutical composition containing the same |
| 06/10/2004 | US20040110736 Cyclic derivatives as modulators of chemokine receptor activity |
| 06/10/2004 | US20040110734 Combinations for the treatment of inflammatory disorders |
| 06/10/2004 | US20040110728 Agonists and antagonists of sphingosine-1-phosphate receptors |
| 06/10/2004 | US20040110718 Anti-HCV nucleoside derivatives |
| 06/10/2004 | US20040110715 Differs from nucleotide sequence of wild-type IFN alpha -17 gene, in that it comprises one or several SNPs (Single Nucleotide Polymorphism[s]); anticarcinogenic and antiproliferative agents; side effect reduction |
| 06/10/2004 | US20040110709 Genetic modification of the lung as a portal for gene delivery |
| 06/10/2004 | US20040110687 Administering immunomodulatory peptides for side effect reduction from cancer chemotherapy or radiotherapy; diarrhea, mucositis, stomatitis and proctitis |
| 06/10/2004 | US20040110661 Rapidly disintegrating tablet comprising an acid-labile active ingredient |
| 06/10/2004 | US20040110289 Obtaining liver cells suspension via proteolytic digestion followed by density gradient centrifugation; liver regeneration and transplantation therapy |
| 06/10/2004 | US20040110287 Culturing pancreatic tissue for use in replenishment of functional glucose-sensing, insulin-secreting pancreatic beta cells; pancreatic injury and diabetes treatments |
| 06/10/2004 | US20040110270 Bacterial composition and its use |
| 06/10/2004 | US20040110180 Comprises enzymatic polypeptide for diagnosis, treatment and prevention of cardiovascular, immune system, nervous system, lipid and cell proliferative disorders; drug screening |
| 06/10/2004 | US20040109905 Method and composition of anthocyanin-rich berry extracts that prevents or inhibits angiogenesis and helicobacter pylori and acts as a powerful antioxidant that provides various health benefits |
| 06/10/2004 | US20040109870 Therapeutic agent for acute hepatitis and chronic hepatitis including hepatic fibrosis and cirrhosis |
| 06/10/2004 | US20040109857 Methods of therapy for b-cell malignancies using antagonist anti-cd40 antibodies |
| 06/10/2004 | US20040109847 Treatment and prophylaxis with 4-1BB-binding agents |
| 06/10/2004 | CA2507887A1 Nucleotide based medicament and method of use for treatment of conditions in humans |
| 06/10/2004 | CA2507616A1 Highly stable pacap/vip-derived peptides |
| 06/10/2004 | CA2506948A1 Pharmaceutical composition comprising a ltb4 antagonist and a cox-2 inhibitor or a combined cox1/2 inhibitor |
| 06/09/2004 | EP1426375A2 Analgesic spiroindole derivatives |
| 06/09/2004 | EP1426370A1 Propanolamine derivative having 1,4 benzodioxane ring |
| 06/09/2004 | EP1426050A1 Jnk inhibitors |
| 06/09/2004 | EP1425389A2 Human antibodies specific for interleukin 15 (il-15) |
| 06/09/2004 | EP1425284A2 Furo- and thienopyrimidine derivatives as angiogenesis inhibitors |
| 06/09/2004 | EP1425281A1 Chemical compounds |
| 06/09/2004 | EP1425280A2 Hetero-bicyclic crf antagonists |
| 06/09/2004 | EP1425279A2 Method for the preparation of crystalline tetrahydrobenzothiepines |
| 06/09/2004 | EP1425258A2 Hydroxyeicosenoic acid analogs |
| 06/09/2004 | EP1425043A1 Method of increasing the presence of glutathione in cells |
| 06/09/2004 | EP1425035A1 Use of biologically active hiv-1 tat, fragments or derivatives thereof, to target and/or to activate antigen-presenting cells, and/or to deliver cargo molecules for preventive or therapeutic vaccination and/or to treat other diseases |
| 06/09/2004 | EP1425030A2 Non-oxidatively metabolized compounds and compositions, synthetic pathways therefor, and uses thereof |
| 06/09/2004 | EP1425020A1 Methods and compositions for treating apoptosis associated disorders |
| 06/09/2004 | EP1425014A1 Diaryl cycloalkyl derivatives, method for producing the same and the use thereof as ppar activators |
| 06/09/2004 | EP1425012A1 Antihelminthic drugs as a treatment for hyperproliferative diseases |
| 06/09/2004 | EP1425004A1 Use of compounds as functional antagonists to the central cannabinoid receptors |
| 06/09/2004 | EP1425001A1 Phenethanolamine derivatives for treatment of respiratory diseases |
| 06/09/2004 | EP1424998A1 Synthesis and use of reagents for improved dna lipofection and/or slow release prodrug and drug therapies |
| 06/09/2004 | EP1424907A1 Oil composition |
| 06/09/2004 | EP1235797B1 Aralkyl-1,2-diamines having calcimimetic activity and preparation mode |
| 06/09/2004 | EP1212323B1 Substituted pyridino pentaazamacrocyle complexes having superoxide dismutase activity |
| 06/09/2004 | EP1171441B1 Morphinoid compounds |
| 06/09/2004 | CN1503796A Polymorphic and other crystalling forms of cis-ftc |
| 06/09/2004 | CN1503792A Phthalazinones derivatives useful as pde 4/7 inhibtors |
| 06/09/2004 | CN1503791A Process for purifying 6-methoxy omeprazole |
| 06/09/2004 | CN1503781A Process for the preparatino of 1,3-substituted indenes and aryl-fused azapolycyclic compounds |
| 06/09/2004 | CN1503774A Carboxylic acid derivative and thereof |
| 06/09/2004 | CN1503672A 6-substituted pyrido-pyrimidines |
| 06/09/2004 | CN1503658A Systems for delivering a cosmetic and/or therapeutic active to oral surfaces using an integral carrier |
| 06/09/2004 | CN1503632A Nutritional composition for immune condition |
| 06/09/2004 | CN1502702A Trehalose-releasing enzyme, and its preparation and use |
| 06/09/2004 | CN1502612A Substituted heterocyclic compounds, process for their preparation and pharmaceutical compositions containing them |
| 06/09/2004 | CN1502358A Use of crataegus pit extract in preparation of medicine for treating gastropathy |
| 06/09/2004 | CN1502355A Oral preparation for reinforcing kidney and strengthening body |
| 06/09/2004 | CN1502351A Composite medicine for treating cholecystitis and gallstone and preparation process thereof |
| 06/09/2004 | CN1502349A Traditional Chinese medicine composition (Bushenzhuangyao Decoction) for reinforcing kidney and strengtening lumbar |
| 06/09/2004 | CN1502346A Application of Psoralca corylifolia in anti-infection of helicobacter pyloric and treating relative diseases |
| 06/09/2004 | CN1502334A Medicinal composition containing Adefovirdipivoxil |
| 06/09/2004 | CN1502331A Anti-angiogenic compositions and methods of use |
| 06/09/2004 | CN1502330A Deodorizing products for oral cavity |
| 06/09/2004 | CN1502329A Deodorizing products for oral cavity |
| 06/09/2004 | CN1502328A Lamiophlomis rotate dispersion table preparation process |
| 06/09/2004 | CN1152962C Antiangiogenic peptides derived from plasminogen, its coded polynucleotide and method of inhibiting vascularization |
| 06/09/2004 | CN1152886C Eplerenone crystalline form exhibiting enhanced dissolution rate |
| 06/09/2004 | CN1152877C Piperazine derivatives |
| 06/09/2004 | CN1152867C Quinazoline derivatives as medicaments |
| 06/09/2004 | CN1152864C Phenylphenanthridines with PDE-IV inhibiting activity |
| 06/09/2004 | CN1152863C Substituted pyridines as selective coclooxygenase-2-inhibitors and composition thereof |
| 06/09/2004 | CN1152717C Oral medicinal preparation |
| 06/09/2004 | CN1152710C Calm stomach tablet for curing gastric disease |
| 06/09/2004 | CN1152707C Medicine for curing chronic diarrhea |
| 06/09/2004 | CN1152695C Medical wine for replenishing vital essence and invigorating vital function and its preparing process |
| 06/09/2004 | CN1152691C Use of chemically-stabilized chloride solution for inhibiting antigen-specific immune response |
| 06/09/2004 | CN1152681C 8a-azalides as veterinary antimicrobial agents for animals |